Tag: Drug

Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs.

Aesther Healthcare Acquisition Corp. • Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol, “OCEA”. Providence, RI and New York, NY, Nov. 01, 2022 (GLOBE NEWSWIRE) — Ocean Biomedical and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) announced today …

[UNDERCOVER] How Bauchi Healthcare workers connive with drug vendors to divert, sell medicines distributed by Government, NGOs

By Usman Babaji Bauchi State government and a host of non-governmental organisations have for years been distributing both free and subsidised drugs across its healthcare centres to support the less privileged. But the generosity is thwarted by a syndicate of corrupt and selfish healthcare workers who connive with drug vendors to shortchange the Sa’adu Zungur’ talakawas. In this report, WikkiTimes …

UNDERCOVER: How Bauchi Health Workers Connive With Drug Vendors To Divert, Sell Medicines Distributed By Government, NGOs

Over eight months after the death of his wife, Ado Musa sheds tears on his cheek whenever he recalls what he described as Rahina Abdullahi’s painful exit. He said Rahina, a mother of four, passed away on December 15, 2021, during childbirth at a Primary Healthcare Centre (PHC) Zwal in Tafawa Balewa Local Government of the State. The 40-year-old man …

Wayne State University researchers use drug repurposing to treat resistant bacterial eye infections – School of Medicine News

Ashok Kumar, Ph.D., at left, and Susmita Das, Ph.D. Researchers from the Department of Ophthalmology, Visual and Anatomical Sciences at the Wayne State University School of Medicine have identified three non-antibiotic drugs can protect the eye from severe inflammation during bacterial infection. The drugs can also be used as adjunct therapy with standard antibiotics to minimize infection outcomes. The study …

Veterinary Drug Market Size, Top Key Players, Types, Applications & Regional Forecasts to 2030 – Travel Adventure Cinema

The Veterinary Drug market report is the most important research for who look for complete information on Veterinary Drug markets. The report covers all information on the global and regional markets including old and future trends for market demand, size, trading, supply, competitors, and prices as well as global predominant vendors’ information. The report also provides a complete overview of …

Drug Delivery Oleogels Could Help the Medicine Go Down

For children who need to take medicines, swallowing pills or tablets can be difficult. Researchers at the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital have developed a drug-delivering gel that is much easier to swallow and could be used to administer a wide range of drugs, not just to children, but to anyone who struggles to swallow …

Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory diarrhea SAN FRANCISCO, CA / ACCESSWIRE / May 25, 2022 / Jaguar Health (NASDAQ:JAGX) announced today that Napo Therapeutics, the Italian corporation established by the company in Italy in 2021 that focuses on …

With personalized medicine, a shelved cancer drug could get another shot – VCU News

By Erin HareVCU Massey Cancer Center A study by Virginia Commonwealth University Massey Cancer Center researchers published in Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies. Triplatin, a 30-year-old drug, has faced a bumpy road on the path to Food and …

Talk about regenerative medicine and potential drug for COVID-19

Cymbeline “Bem” Culiat, co-founder, president and chief science officer of NellOne Therapeutics Inc. in Knoxville and a former molecular geneticist at Oak Ridge National Laboratory, will speak virtually to Friends of ORNL at noon Tuesday, Feb. 8. She will speak on “Future Applications in Regenerative Medicine” and part of her talk will be devoted to a potential treatment for sufferers …